KDM6B and neuroblastoma: In line with these results, BE(2)-C and SK-N-AS cells with KDM6B overexpression generated much smaller tumors in immunodeficient mice relative to their vector control counterparts (Fig. 2d), indicating that high KDM6B expression reduced tumorigenicity of neuroblastoma cells.